Abstract
Interleukin-2 (IL-2) and T cell subpopulations were evaluated in children with rheumatic heart disease (RHD). Three groups were included: 13 patients with active RHD, 12 with non-active RHD, and 14 control children. Serum IL-2 and T cell subpopulations were measured by radioimmunoassay and monoclonal antibodies respectively. Patients with active RHD showed a significant increase in IL-2 concentrations and helper:suppressor (H:S) ratio compared with controls with a mean (SEM) IL-2 of 3.48 (0.62) v 1.26 (0.16) U/ml and H:S ratio 2.31 (0.14) v 1.66 (0.04). There was a significant decrease in T suppressor (CD8+) and pan T (CD3+) cells compared with controls with a mean (SEM) for CD8+ of 23.75 (1.19) v 32.23 (0.56)% and CD3+ of 79.55 (0.94) v 85.00 (0.11)%. Patients with non-active RHD showed a significant decrease only in the CD3+ cells (78.20 (0.20)%) when compared with controls. A deficiency of CD3+ cells is a constant finding in patients with RHD, whether the disease is active or not. There was a significant increase in IL-2 concentration with a significant decrease in CD8+ cells in patients with active RHD in comparison with the non-active group (mean (SEM) IL-2 of 3.48 (0.62) v 1.85 (0.24) U/ml and CD8+ of 23.75 (1.19) v 28.83 (1.91)%). Thus an increase in IL-2 and a decrease in CD8+ cells may be related to rheumatic activity. T helper (CD4+) cells did not differ significantly between groups.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bhatnagar P. K., Nijhawan R., Prakash K. T cell subsets in acute rheumatic fever, rheumatic heart disease and acute glomerulonephritis cases. Immunol Lett. 1987 Jul;15(3):217–219. doi: 10.1016/0165-2478(87)90027-7. [DOI] [PubMed] [Google Scholar]
- Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
- Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
- Gray E. D., Abdin Z. H., el Kholy A., Mansour M., Miller L. C., Zaher S., Kamel R., Regelmann W. E. Augmentation of cytotoxic activity by mitogens in rheumatic heart disease. J Rheumatol. 1988 Nov;15(11):1672–1676. [PubMed] [Google Scholar]
- Lueker R. D., Williams R. C., Jr Decreased reactivity of lymphocytes in mixed-leukocyte culture from patients with rheumatic fever. Circulation. 1972 Oct;46(4):655–660. doi: 10.1161/01.cir.46.4.655. [DOI] [PubMed] [Google Scholar]
- Regelmann W. E., Gray E. D., Wannamaker L. W., Lebien T. W., Mansour M., el Kholy A., Abdin Z. Lymphocyte subpopulations in rheumatic heart disease. J Rheumatol. 1987 Feb;14(1):23–27. [PubMed] [Google Scholar]
- Scheynius A., Fischer T., Forsum U., Klareskog L. Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. Clin Exp Immunol. 1984 Jan;55(1):81–90. [PMC free article] [PubMed] [Google Scholar]
- Svedersky L. P., Shepard H. M., Spencer S. A., Shalaby M. R., Palladino M. A. Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2. J Immunol. 1984 Aug;133(2):714–718. [PubMed] [Google Scholar]